DR. ELLIOT STRASHIN TO ACQUIRE MORE STOCK Section 102.1 of the Securities Act (Ontario) Section 176 of the Securities Act (Alberta) Section 11 of the Securities Act (British Columbia)

TRILLIUM NORTH MINERALS LTD

500 – 20 Maud St., TORONTO Ontario, CANADA M5V 2M5 Telephone: (416) 504-0077 Fax: (416) 504-6019 www.trilliumnorth.com

402 – 905 West Pender Street, VANCOUVER British Columbia, CANADA V6C 1L6 Telephone: (604) 681-1909 Fax: (604) 689-5930 TSX:V Symbol: TNM

August 30, 2012 NEWS RELEASE FOR IMMEDIATE RELEASE

DR. ELLIOT STRASHIN TO ACQUIRE MORE STOCK

Section 102.1 of the Securities Act (Ontario)

Section 176 of the Securities Act (Alberta)

Section 11 of the Securities Act (British Columbia)

In compliance with the requirements of National Instrument 62-103, Dr. Elliot Strashin, President of Trillium North Minerals Ltd., announces that he is intending to purchase common shares of the Corporation on the open market and/or through private placement amounting up to 2% of the issued capital of the Corporation. Purchases would be made through the facilities of TSX Venture Exchange at prevailing market prices or in compliance with the requirements of the exchange, and be at the discretion of the purchaser. Purchases would not commence until 5 days after the date hereof and would cease on the date that is 6 months thereafter.

Dr. Strashin currently holds together with all joint actors 21,082,864 common shares of Trillium (of which he holds 2,313,847 common shares directly and 18,769,017 common shares indirectly) representing 26.69% of the issued and outstanding common shares of Trillium. Dr. Strashin together with all joint actors hold their Trillium common shares for investment purposes and may in the future acquire additional securities of Trillium, dispose of some or all of their current holdings in Trillium, or maintain their current holdings in Trillium.

The issuance of this news release is not an admission that an entity named or referred to herein owns or controls any described securities herein or is a joint actor with another named or referred to entity.

To obtain a copy of the report relating to the above matter, please call Dr. Strashin at (416) 504-0077 xt 22.

Dr. Elliot Strashin, President

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.